Multiple Choice
In a changing clinical environment, the indirect immunofluorescent assay (IFA) has been replaced with the enzyme immunoassay (EIA) . A disadvantage of this trade-off to EIA is
A) lower cost.
B) that it is slower in producing results.
C) that it is more technically challenging and requires more training and experience.
D) that it is problematic for patients with less than a 1:160 antinuclear antibody (ANA) titer.
Correct Answer:
Verified
Correct Answer:
Verified
Q3: Match the following emerging technology with the
Q4: Magnetic labeling application uses<br>A)automated DNA sequences.<br>B)DNA probe
Q5: Match the type of enzyme immunoassay (EIA)
Q6: Fluorescent molecules in immunofluorescent techniques are used
Q7: Match the assays and definitions.<br>-Inhibition immunofluorescent assay<br>A)Antibodies
Q9: FISH technology<br>A)uses recombinant DNA technology.<br>B)detects hematopathologic chromosomal
Q10: An advantage of enzyme immunoassay (EIA) compared
Q11: Match the following emerging technology with the
Q12: Match the assays and definitions.<br>-Direct immunofluorescent assay<br>A)Antibodies
Q13: A fluorescent substance or dye absorbs light